Science 37
Science 37 runs direct-to-patient clinical trial sites that expand patient access to research.
Founded
2014Science 37 runs direct-to-patient clinical trial sites that expand patient access to research.
science37.comCrawled Oct 15, 2026
The page reflects on Science 37’s webinar, “Mental Health & Clinical Trials in the Black Community.”
The page discusses the importance of patient recruitment to clinical research success.
The page discusses news from the U.K. related to Cervical Health Awareness Month.
The page discusses increased adoption of agile, decentralized, and patient-centric approaches.
Science 37 offers jobs in research, nursing, and operations and aims to make clinical trials accessible worldwide.
Science 37 says its FDA-inspected direct-to-patient clinical trial site makes research more accessible.
Science 37 partners with CROs, biotechs, pharma, and advocacy groups to improve recruitment, retention, and trial access through its Direct-to-Patient Site direct-to-patient model.
Science 37 provides support through a contact form, phone number (984) 377-3737, and connections to relevant teams.
Science 37 expands trial access, reaching a new and more diverse patient population. Deliver patient-friendly hybrid and decentralized clinical trials, with clinical research that works for everyone.,The Virtual Clinical Trial Direct-to-Patient Site—DCT and Hybrid Research
GitHubRepository owner
Science 37 and Tufts CSDD publish a study on direct-to-patient clinical trial site performance. The research examines the direct-to-patient site model. It reports that the model enrolls 20% to 30% of study participants and has an 86% completion rate, outperforming industry benchmarks.
May 2026 · Science 37News article
Science 37 completes its third FDA inspection of its direct-to-patient site in a pivotal Phase 3 rare disease trial. The inspection receives a No Action Indicated categorization, with no Form 483 issued. The outcome validates the site's quality.
Oct 2025 · Science 37News article
Science 37 and Catalent announce a strategic partnership for direct-to-patient delivery of investigational medicines. The collaboration supports enrollment of nearly 1,700 patients across 17 studies and more than 6,400 shipments. The companies say the model enables universal access to clinical research.
Sep 2025 · Science 37News article